HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular repair for diverse pathologies of the thoracic aorta: an initial decade of experience.

AbstractBACKGROUND:
Endovascular grafts have rapidly evolved as a minimally invasive treatment for a variety of acute and chronic disorders of the thoracic aorta. Application of this technology at a single center is reported.
STUDY DESIGN:
Between 1998 and 2007, 197 patients underwent thoracic endovascular aortic repair. Primary indications included degenerative aneurysms (n = 121), type B aortic dissection (n = 44), mycotic aneurysms (n = 9), traumatic disruptions (n = 9), intramural hematoma (n = 5), pseudoaneurysm (n = 4), and miscellaneous pathology (n = 5). An analysis of patient demographics, periprocedural records, complications, reinterventions, and survival was conducted.
RESULTS:
Thirty-day mortality was 6%, which was lowest among patients undergoing treatment for a degenerative thoracic aortic aneurysm (2.4%, 3 of 121). Major adverse events included stroke in 3%, spinal cord ischemia in 2%, peripheral vascular repair in 4.5%, renal failure in 4.5%, and open conversion in one patient (0.5%). Both preoperative serum creatinine (odds ratio 1.44, 95% CI 1.02 to 2.04, p = 0.039) and number of endograft components (odds ratio 1.43, 95% CI 1.01 to 2.01, p = 0.043) were predictors of major adverse events. Kaplan-Meier analysis revealed a reduction in late survival among patients with preoperative creatinine >or=1.8 mg/dL (p < 0.001). One- and 5-year intervention-free survivals were 77%+/-3% and 41%+/-6%, respectively.
CONCLUSIONS:
Thoracic endovascular aortic repair represents an effective treatment for a variety of pathologic states. But the risk-benefit analysis for thoracic endovascular aortic repair should carefully consider the extent of disease, pathologic condition, and renal function.
AuthorsElliot L Chaikof, Christopher Mutrie, Karthik Kasirajan, Ross Milner, Edward P Chen, Ravi K Veeraswamy, Thomas F Dodson, Atef A Salam
JournalJournal of the American College of Surgeons (J Am Coll Surg) Vol. 208 Issue 5 Pg. 802-16; discussion 816-8 (May 2009) ISSN: 1879-1190 [Electronic] United States
PMID19476841 (Publication Type: Journal Article)
Chemical References
  • Creatinine
Topics
  • Aged
  • Aged, 80 and over
  • Aortic Dissection (surgery)
  • Aortic Aneurysm, Thoracic (mortality, pathology, surgery)
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation (adverse effects)
  • Cause of Death
  • Creatinine (blood)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Postoperative Complications (epidemiology)
  • Prosthesis Failure
  • Risk Assessment
  • Stroke (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: